Alemtuzumab in Treating Patients With Advanced Chronic Lymphocytic Leukemia That Did Not Respond to Previous Fludarabine

NCT00274976 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Leukemia

Interventions

BIOLOGICAL: alemtuzumab

Sponsor

German CLL Study Group